SCHEMBL29429803

SCHEMBL29429803

c1cc(-c2nc(-c3cccc(-n4c5ccccc5c5ccccc54)c3)nc(-c3cccc(-n4c5ccccc5c5ccccc54)c3)n2)cc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ ATM Q13315 1/20 0.53
▸ KMT2A Q03164 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ GAA P10253 1/20 0.39
▸ IL1R1 P14778 1/20 0.37
▸ PLA2G10 O15496 1/20 0.37
▸ ABCG2 Q9UNQ0 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ FOLH1 Q04609 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ NR1I3 Q14994 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30309408 1.00 KDM4E (0.53) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL4547021 1.00 KDM4E (0.53) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL30516185 0.97 L3MBTL1 (0.55) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL12455311 0.97 L3MBTL1 (0.55) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL13010236 0.97 L3MBTL1 (0.55) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL24609466 0.95 L3MBTL1 (0.48) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL20232380 0.95 L3MBTL1 (0.53) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL15458419 0.94 ATM (0.52) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL15458528 0.94 ATM (0.52) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL24970332 0.94 L3MBTL1 (0.52) KDM4EL3MBTL1ATMKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4592297-A1 AN ORGANIC BORON COMPOUND, AN ORGANIC LIGHT EMITTING DIODE COMPRISING THE ORGANIC BORON COMPOUND, A USE OF THE DIODE, AND A CONSUMER PRODUCT Noctiluca S.A. (PL) 2025-07-30 — — EP claimed
US-20240423011-A1 PLANAR LIGHT-EMITTING TRANSISTOR DEVICE CAPABLE OF SURFACE LIGHT SOURCE EMISSION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2024-12-19 — — US claimed
US-20230311255-A1 SYSTEM FOR HOLD, CLAMP AND POSITION OBJECTS CNC ILERI TEKNOLOJI MOHENDISLIK SANAYI VE TICARET LIMITED SIRKETI (TR) 2023-10-05 — — US claimed
EP-4204182-A1 SYSTEM FOR HOLD, CLAMP AND POSITION OBJECTS CNC Ileri Teknoloji Mühendislik Sanayi ve Ticaret Limited Sirketi (TR) 2023-07-05 — — EP claimed
WO-2023078156-A1 PLANAR LIGHT-EMITTING TRANSISTOR DEVICE CAPABLE OF SURFACE LIGHT SOURCE EMISSION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 中国科学院化学研究所 2023-05-11 — — WO claimed
CN-116096126-A Planar light-emitting transistor for surface light source emergent and preparation method and application thereof 中国科学院化学研究所 2023-05-09 — — CN claimed
CN-116096127-A Laminated light-emitting field effect transistor and preparation method and application thereof 中国科学院化学研究所 2023-05-09 — — CN claimed
WO-2026107259-A1 BIOMARKERS FOR CANCER DETECTION NEXOSOME ONCOLOGY LLC (US) 2026-05-21 — — WO disclosed
US-12581795-B2 Display device and method for manufacturing same SHARP KABUSHIKI KAISHA (JP) 2026-03-17 — — US disclosed
US-20250383355-A1 BIOMARKERS FOR ENDOMETRIAL CANCER FUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA (ES) 2025-12-18 — — US disclosed
US-12495665-B2 Display device having carrier blocking section between pixels SHARP KABUSHIKI KAISHA (JP) 2025-12-09 — — US disclosed
US-12486528-B2 Compositions and methods for measuring and inhibiting calpain-5 activity THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2025-12-02 — — US disclosed
EP-4592297-A1 AN ORGANIC BORON COMPOUND, AN ORGANIC LIGHT EMITTING DIODE COMPRISING THE ORGANIC BORON COMPOUND, A USE OF THE DIODE, AND A CONSUMER PRODUCT Noctiluca S.A. (PL) 2025-07-30 — — EP disclosed
US-20220170938-A1 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER INTEGRATED DIAGNOSTICS, INC. 2022-06-02 — — US disclosed
WO-2022085097-A1 DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME シャープ株式会社 2022-04-28 — — WO disclosed
WO-2022073065-A1 TRIPLET QUENCHER THE UNIVERSITY OF QUEENSLAND (AU) 2022-04-14 — — WO disclosed
US-11293018-B2 Manipulation of nuclear architecture THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2022-04-05 — — US disclosed
US-20220096593-A1 METHOD AND COMPOSITIONS COMPRISING A CT20 PEPTIDE UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. 2022-03-31 — — US disclosed
US-20220073931-A1 ANTISENSE OLIGONUCLEOIDES OF GLUTATHIONE S-TRANSFERASES FOR CANCER TREATMENT ATSO CORP AFFAIRS S A DE C V (MX) 2022-03-10 — — US disclosed
WO-2022038694-A1 DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME シャープ株式会社 2022-02-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12581795-B2 Display device and method for manufacturing same EPHA4, NECTIN4, L1CAM KDM4E 3580/4885L3MBTL1 362/4885ATM 4341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback